@NP	Functional Repair	1
@NP	the Corticospinal Tract	22
@NP	Delayed Transplantation	49
@NP	Olfactory Ensheathing Cells	76
@NP	Adult Rats Naghmeh Keyvan-Fouladi , Geoffrey Raisman ,	107
@NP	Adult Rats	107
@NP	Naghmeh Keyvan-Fouladi , Geoffrey Raisman ,	119
@NP	Naghmeh Keyvan-Fouladi	119
@NP	Geoffrey Raisman	143
@NP	Ying Li Division of Neurobiology	165
@NP	Ying Li Division	165
@NP	Neurobiology	185
@NP	Norman	199
@NP	Sadie Lee Research Centre	210
@NP	Medical Research Council	237
@NP	National Institute for Medical Research	263
@NP	National Institute	263
@NP	Medical Research	286
@NP	London , NW7 1AA , United Kingdom Adult rats	304
@NP	London	304
@NP	NW7 1AA , United Kingdom Adult rats	312
@NP	their forepaws	368
@NP	a piece of food	395
@NP	a piece	395
@NP	food	406
@NP	Destruction	412
@NP	the dorsal corticospinal tract	427
@NP	one side at the level of the first cervical segment	461
@NP	one side	461
@NP	the level of the first cervical segment	473
@NP	the level	473
@NP	the first cervical segment	486
@NP	the use of the ipsilateral forepaw for retrieval for at least 6 months	523
@NP	the use	523
@NP	the ipsilateral forepaw for retrieval for at least 6 months	534
@NP	the ipsilateral forepaw	534
@NP	retrieval for at least 6 months	562
@NP	retrieval	562
@NP	at least 6 months	576
@NP	operation	600
@NP	a variable amount of the corticospinal tract	617
@NP	a variable amount	617
@NP	the corticospinal tract	638
@NP	there	674
@NP	a proportionate persistence of retrieval	684
@NP	a proportionate persistence	684
@NP	retrieval	715
@NP	lesioned rats that had shown no retrieval for 8 weeks after operation	729
@NP	lesioned rats	729
@NP	no retrieval for 8 weeks	758
@NP	no retrieval	758
@NP	8 weeks	775
@NP	operation	789
@NP	a suspension of olfactory ensheathing cells	800
@NP	a suspension	800
@NP	olfactory ensheathing cells	816
@NP	the lesion site	862
@NP	1 and 3 weeks after transplantation	896
@NP	1 and 3 weeks	896
@NP	transplantation	916
@NP	all rats with transplants bridging the lesion site	933
@NP	all rats	933
@NP	transplants bridging the lesion site	947
@NP	transplants	947
@NP	the lesion site	968
@NP	retrieval	992
@NP	the ipsilateral forepaw	1005
@NP	Biotin dextran anterograde	1030
@NP	shows	1065
@NP	corticospinal axons	1084
@NP	the bridge	1113
@NP	≈ 10 mm in the distal part of the corticospinal tract	1148
@NP	≈ 10 mm	1148
@NP	the distal part of the corticospinal tract	1157
@NP	the distal part	1157
@NP	the corticospinal tract	1176
@NP	terminal arborizations	1212
@NP	the spinal gray matter	1238
@NP	Functional recovery	1262
@NP	only ≈ 1 % of the corticospinal tract axons	1297
@NP	only ≈ 1 %	1297
@NP	only ≈	1297
@NP	the corticospinal tract axons	1309
@NP	Introduction	1353
@NP	We	1366
@NP	unilateral lesions of the dorsal corticospinal tract -LRB- CST -RRB-	1399
@NP	unilateral lesions	1399
@NP	the dorsal corticospinal tract -LRB- CST -RRB-	1421
@NP	the dorsal corticospinal tract	1421
@NP	CST	1453
@NP	forepaw retrieval -LRB- DFR -RRB-	1475
@NP	forepaw retrieval	1475
@NP	DFR	1494
@NP	the ipsilateral forepaw -LRB- Li et al. , 1997 -RRB-	1502
@NP	the ipsilateral forepaw	1502
@NP	Li	1527
@NP	et al. , 1997	1530
@NP	et al.	1530
@NP	1997	1538
@NP	Olfactory ensheathing cells -LRB- OECs -RRB-	1545
@NP	Olfactory ensheathing cells	1545
@NP	OECs	1574
@NP	the lesion site	1598
@NP	the time of injury	1617
@NP	the time	1617
@NP	injury	1629
@NP	a recovery of DFR	1644
@NP	a recovery	1644
@NP	DFR	1658
@NP	The potential value of such an approach to human spinal cord injuries	1663
@NP	The potential value	1663
@NP	such an approach to human spinal cord injuries	1686
@NP	such an approach	1686
@NP	human spinal cord injuries	1706
@NP	account	1756
@NP	the inevitable delay	1764
@NP	clinical practice between the time of injury	1804
@NP	clinical practice	1804
@NP	the time of injury	1830
@NP	the time	1830
@NP	injury	1842
@NP	the time when the patient is sufficiently stable	1853
@NP	the time	1853
@NP	the patient	1867
@NP	no further spontaneous recovery	1922
@NP	transplantation	1978
@NP	most previous studies of repair	1998
@NP	most previous studies	1998
@NP	repair	2023
@NP	transplantation	2031
@NP	the same time	2064
@NP	the lesions	2078
@NP	Imaizumi et al. , 1998 ; Ramo ' n-Cueto et al. , 1998 , 2000	2101
@NP	Imaizumi et al.	2101
@NP	Imaizumi	2101
@NP	et al.	2110
@NP	1998 ; Ramo ' n-Cueto et al.	2118
@NP	1998	2118
@NP	Ramo ' n-Cueto et al.	2124
@NP	Ramo ' n-Cueto	2124
@NP	Ramo '	2124
@NP	et al.	2138
@NP	1998 , 2000	2146
@NP	1998	2146
@NP	2000	2152
@NP	functional improvement	2174
@NP	delayed transplantation	2221
@NP	fetal spinal cord	2248
@NP	cerebral tissue	2267
@NP	adult peripheral nerve tissue	2288
@NP	Coumans	2319
@NP	et al. , 2001 ; Zurita et al. , 2001	2327
@NP	et al.	2327
@NP	2001 ; Zurita et al.	2335
@NP	2001	2335
@NP	Zurita et al.	2341
@NP	Zurita	2341
@NP	et al.	2348
@NP	2001	2356
@NP	chronic rat spinal cord lesions	2367
@NP	Lu et al. -LRB- 2002 -RRB- and Plant et al. -LRB- 2003 -RRB-	2400
@NP	Lu et al. -LRB- 2002 -RRB-	2400
@NP	Lu	2400
@NP	et al. -LRB- 2002 -RRB-	2403
@NP	et al.	2403
@NP	2002	2411
@NP	Plant et al. -LRB- 2003 -RRB-	2421
@NP	Plant	2421
@NP	et al. -LRB- 2003 -RRB-	2427
@NP	et al.	2427
@NP	2003	2435
@NP	an improvement of locomotor function	2455
@NP	an improvement	2455
@NP	locomotor function	2473
@NP	delayed transplantation	2498
@NP	OECs into complete or incomplete thoracic spinal lesions	2525
@NP	OECs	2525
@NP	complete or incomplete thoracic spinal lesions	2535
@NP	the present study	2586
@NP	we	2605
@NP	OECs	2628
@NP	DFR	2659
@NP	transplantation	2668
@NP	2 months	2699
@NP	complete unilateral destruction of the CST	2714
@NP	complete unilateral destruction	2714
@NP	the CST	2749
@NP	Materials and Methods Pretraining .	2759
@NP	Materials and Methods	2759
@NP	Materials	2759
@NP	Methods	2773
@NP	3 successive days before operation	2797
@NP	3 successive days	2797
@NP	operation	2822
@NP	adult	2833
@NP	body	2840
@NP	weight , 200 -- 240 gm	2845
@NP	weight	2845
@NP	200	2853
@NP	240 gm	2857
@NP	female rats of a locally inbred Albino Swiss strain	2865
@NP	female rats	2865
@NP	a locally inbred Albino Swiss strain	2880
@NP	the testing cage	2936
@NP	a piece of food	2954
@NP	a piece	2954
@NP	food	2965
@NP	a slit in the front of the cage , and the number of times the right	2992
@NP	a slit	2992
@NP	the front of the cage , and the number of times the right	3002
@NP	the front of the cage	3002
@NP	the front	3002
@NP	the cage	3015
@NP	the number of times the right	3029
@NP	the number of times	3029
@NP	the number	3029
@NP	times	3043
@NP	the right	3049
@NP	paws	3068
@NP	an overall total of 50 retrievals	3100
@NP	an overall total	3100
@NP	50 retrievals	3120
@NP	The majority of rats	3135
@NP	The majority	3135
@NP	rats	3151
@NP	both paws	3160
@NP	10 % of rats	3202
@NP	10 %	3202
@NP	rats	3209
@NP	an asymmetry of use	3221
@NP	an asymmetry	3221
@NP	use	3237
@NP	15/35	3242
@NP	these	3253
@NP	Lesion .	3282
@NP	we	3298
@NP	the functional effect of unilateral lesions of the CST	3317
@NP	the functional effect	3317
@NP	unilateral lesions of the CST	3342
@NP	unilateral lesions	3342
@NP	the CST	3364
@NP	involvement of other tracts in the dorsal columns	3383
@NP	involvement	3383
@NP	other tracts in the dorsal columns	3398
@NP	other tracts	3398
@NP	the dorsal columns	3414
@NP	avoiding damage to the lateral columns	3445
@NP	avoiding damage	3445
@NP	the lateral columns	3464
@NP	we	3485
@NP	a stereotaxic approach	3493
@NP	we	3525
@NP	the lesion size and position	3554
@NP	the CST	3586
@NP	Anesthetized rats -LRB- n = 54 -RRB-	3595
@NP	Anesthetized rats	3595
@NP	n	3614
@NP	54	3616
@NP	a stereotaxic frame	3636
@NP	the neck	3662
@NP	the dorsal surface of the spinal cord	3679
@NP	the dorsal surface	3679
@NP	the spinal cord	3701
@NP	the level of the first	3732
@NP	the level	3732
@NP	the first	3745
@NP	second cervical segments	3758
@NP	a midline incision	3791
@NP	A stainless steel electrode	3811
@NP	250 µm diameter	3842
@NP	1 mm of the tip	3879
@NP	1 mm	3879
@NP	the tip	3887
@NP	a depth of 1 mm at a point 500µm lateral	3912
@NP	a depth	3912
@NP	1 mm at a point 500µm lateral	3923
@NP	1 mm	3923
@NP	a point 500µm lateral	3931
@NP	the midline	3956
@NP	The identification of the midline	3969
@NP	The identification	3969
@NP	the midline	3991
@NP	the presence of the median sagittal vein	4021
@NP	the presence	4021
@NP	the median sagittal vein	4037
@NP	this	4072
@NP	some variation in electrode placement	4118
@NP	some variation	4118
@NP	electrode placement	4136
@NP	Approximately equal numbers of rats	4157
@NP	Approximately equal numbers	4157
@NP	rats	4188
@NP	the right	4210
@NP	sides	4229
@NP	The CST	4236
@NP	a heat lesion	4261
@NP	a radiofrequency lesion device	4287
@NP	RFG-3C RF ; Radionics Inc. , Burlington , MA	4319
@NP	RFG-3C RF	4319
@NP	Radionics Inc. , Burlington , MA	4330
@NP	10 V for 1 min	4375
@NP	10 V	4375
@NP	1 min	4384
@NP	This	4391
@NP	ovoid lesions of 0.5 -- 1.0 mm in diameter	4419
@NP	ovoid lesions of 0.5	4419
@NP	ovoid lesions	4419
@NP	0.5	4436
@NP	1.0 mm in diameter	4440
@NP	1.0 mm	4440
@NP	diameter	4449
@NP	the size of the lesions -LRB- 0.5 -- 1.0 mm -RRB-	4467
@NP	the size	4467
@NP	the lesions -LRB- 0.5 -- 1.0 mm -RRB-	4479
@NP	the lesions	4479
@NP	0.5 -- 1.0 mm	4492
@NP	0.5	4492
@NP	1.0 mm	4496
@NP	that of the target CST -LRB- 0.5 mm -RRB-	4530
@NP	that	4530
@NP	the target CST -LRB- 0.5 mm -RRB-	4538
@NP	the target CST	4538
@NP	0.5 mm	4554
@NP	slight errors in electrode placement	4563
@NP	slight errors	4563
@NP	electrode placement	4580
@NP	sparing of varying amounts of the target	4607
@NP	sparing	4607
@NP	varying amounts of the target	4618
@NP	varying amounts	4618
@NP	the target	4637
@NP	Postoperative testing .	4649
@NP	Three days	4672
@NP	operation	4689
@NP	the rats	4700
@NP	the testing cage and the use of the right	4728
@NP	the testing cage	4728
@NP	the use of the right	4749
@NP	the use	4749
@NP	the right	4760
@NP	paws	4779
@NP	50 retrievals three times per week for 8 successive weeks	4799
@NP	50 retrievals	4799
@NP	three times	4813
@NP	week for 8 successive weeks	4829
@NP	week	4829
@NP	8 successive weeks	4838
@NP	21 rats	4861
@NP	either retention of ipsilateral DFR or a loss of DFR	4881
@NP	retention of ipsilateral DFR	4888
@NP	retention	4888
@NP	ipsilateral DFR	4901
@NP	a loss of DFR	4920
@NP	a loss	4920
@NP	DFR	4930
@NP	a progressive return	4947
@NP	subsequent histology	4969
@NP	all cases	5005
@NP	the lesions of the CST	5015
@NP	the lesions	5015
@NP	the CST	5030
@NP	This series of incomplete lesions	5055
@NP	This series	5055
@NP	incomplete lesions	5070
@NP	the correlation between lesion size and DFR	5107
@NP	the correlation	5107
@NP	lesion size and DFR	5131
@NP	33 rats	5155
@NP	the ipsilateral forepaw for retrieval	5180
@NP	the ipsilateral forepaw	5180
@NP	retrieval	5208
@NP	the 8 weeks of postlesion testing	5222
@NP	the 8 weeks	5222
@NP	postlesion testing	5237
@NP	7	5257
@NP	the completeness of the lesions	5276
@NP	the completeness	5276
@NP	the lesions	5296
@NP	calcium calmodulin kinase II -LRB- CaM-II -RRB- immunostaining	5324
@NP	the remaining 26 rats	5393
@NP	12	5416
@NP	transplants of OECs	5428
@NP	transplants	5428
@NP	OECs	5443
@NP	2	5464
@NP	injections of OEC-conditioned medium -LRB- as a control -RRB-	5475
@NP	injections	5475
@NP	OEC-conditioned medium -LRB- as a control -RRB-	5489
@NP	OEC-conditioned medium	5489
@NP	a control	5516
@NP	These rats	5528
@NP	three times per week	5551
@NP	three times	5551
@NP	week	5567
@NP	an additional 8 weeks	5576
@NP	the remaining 12 lesioned rats	5602
@NP	the remaining	5602
@NP	12 lesioned rats	5616
@NP	transplants	5642
@NP	six	5656
@NP	once a week	5672
@NP	an additional 16 weeks	5688
@NP	a total of 24 weeks	5715
@NP	a total	5715
@NP	24 weeks	5726
@NP	Cell culture .	5737
@NP	Cell	5737
@NP	culture	5742
@NP	Tissue	5751
@NP	the outer nerve and glomerular layers of the rat olfactory bulb	5777
@NP	the outer nerve	5777
@NP	glomerular layers of the rat olfactory bulb	5797
@NP	glomerular layers	5797
@NP	the rat olfactory bulb	5818
@NP	0.1 % trypsin for 15 min at 37 °C	5855
@NP	0.1 % trypsin	5855
@NP	15 min at 37 °C	5872
@NP	15 min	5872
@NP	37 °C	5882
@NP	35mmdishes coated with poly-L-lysine	5901
@NP	35mmdishes	5901
@NP	poly-L-lysine	5924
@NP	14 -- 17 d in DMEM -- F-12 medium	5956
@NP	14 -- 17 d in DMEM --	5956
@NP	14	5956
@NP	17 d in DMEM	5959
@NP	17 d	5959
@NP	DMEM	5967
@NP	10 % FCS -LRB- 3133-028 ; Invitrogen , Paisley , UK -RRB-	5994
@NP	10 % FCS	5994
@NP	3133-028 ; Invitrogen , Paisley , UK	6003
@NP	3133-028	6003
@NP	Invitrogen , Paisley , UK	6013
@NP	Each dish	6039
@NP	1 million cells , of which 50 % were p75-positive	6058
@NP	1 million cells	6058
@NP	50 %	6085
@NP	Schwann-like OECs and 50 %	6108
@NP	Schwann-like OECs	6108
@NP	50 %	6130
@NP	fibronectin	6139
@NP	FN	6152
@NP	positive olfactory nerve fibroblasts -LRB- Li et al. , 1998 -RRB-	6156
@NP	positive olfactory nerve fibroblasts	6156
@NP	Li	6194
@NP	et al. , 1998	6197
@NP	et al.	6197
@NP	1998	6205
@NP	Fourteen rats that had shown complete absence of DFR for 8 weeks after lesion	6229
@NP	Fourteen rats	6229
@NP	complete absence of DFR	6258
@NP	complete absence	6258
@NP	DFR	6278
@NP	8 weeks	6286
@NP	lesion	6300
@NP	the spinal cord	6332
@NP	the same	6369
@NP	the lesioning	6397
@NP	a solenoidcontrolled air pressure device	6412
@NP	5 µl	6462
@NP	a suspension of 25 x 106/ml OECs -LRB- n = 12 -RRB-	6470
@NP	a suspension of 25	6470
@NP	a suspension	6470
@NP	25	6486
@NP	106/ml OECs -LRB- n = 12 -RRB-	6491
@NP	106/ml OECs	6491
@NP	n	6504
@NP	12	6508
@NP	OEC-conditioned medium -LRB- n = 2 -RRB-	6515
@NP	OEC-conditioned medium	6515
@NP	n	6539
@NP	2	6543
@NP	a glass micropipette -LRB- 100 -- 150 µm tip -RRB-	6550
@NP	a glass micropipette	6550
@NP	100 -- 150 µm tip	6572
@NP	100	6572
@NP	150 µm tip	6576
@NP	the lesion site -LRB- Li et al. , 1997 -RRB-	6593
@NP	the lesion site	6593
@NP	Li	6610
@NP	et al. , 1997	6613
@NP	et al.	6613
@NP	1997	6621
@NP	Axon tracing .	6628
@NP	Axon	6628
@NP	Four rats with transplants and six rats with lesion	6642
@NP	Four rats	6642
@NP	transplants and six rats with lesion	6657
@NP	transplants	6657
@NP	six rats with lesion	6673
@NP	six rats	6673
@NP	lesion	6687
@NP	CST axons	6722
@NP	A total	6733
@NP	10 % biotin dextran -LRB- BD -RRB-	6744
@NP	10 % biotin dextran	6744
@NP	BD	6764
@NP	0.5 µl ; molecular weight , 10,000 ; Molecular Probes , Eugene , OR	6769
@NP	0.5 µl	6769
@NP	molecular weight , 10,000 ; Molecular Probes , Eugene , OR	6777
@NP	molecular weight , 10,000	6777
@NP	molecular weight	6777
@NP	10,000	6795
@NP	Molecular Probes , Eugene , OR	6803
@NP	Molecular Probes	6803
@NP	Eugene	6821
@NP	OR	6829
@NP	Brandt and Apkarian	6834
@NP	1992	6855
@NP	saline	6864
@NP	anesthesia	6906
@NP	a 100 µm tip glass micropipette	6925
@NP	each of the four points	6960
@NP	each	6960
@NP	the four points	6968
@NP	the mediolateral extent	6990
@NP	the contralateral sensorimotor cortex -LRB- Li et al. , 1998 -RRB-	7017
@NP	the contralateral sensorimotor cortex	7017
@NP	Li	7056
@NP	et al. , 1998	7059
@NP	et al.	7059
@NP	1998	7067
@NP	2 weeks	7073
@NP	4 % paraformaldehyde	7103
@NP	Histology	7124
@NP	immunostaining on semithin sections	7139
@NP	immunostaining	7139
@NP	semithin sections	7157
@NP	rats	7176
@NP	deep terminal anesthesia	7201
@NP	a mixture of 1 % paraformaldehyde and 1 % glutaraldehyde	7231
@NP	a mixture	7231
@NP	1 % paraformaldehyde and 1 % glutaraldehyde	7244
@NP	1 % paraformaldehyde	7244
@NP	1 % glutaraldehyde	7268
@NP	0.1 M PBS	7289
@NP	resin	7315
@NP	Coronal sections -LRB- 1 -- 2 µm -RRB-	7322
@NP	Coronal sections	7322
@NP	1 -- 2 µm	7340
@NP	1	7340
@NP	2 µm	7342
@NP	the lesion/transplant site	7365
@NP	ethanolic sodium hydroxide for 9 min for resin etching	7406
@NP	ethanolic sodium hydroxide	7406
@NP	9 min for resin etching	7437
@NP	9 min	7437
@NP	resin etching	7447
@NP	a slide with 1:1000 anti-FN -LRB- Invitrogen -RRB-	7483
@NP	a slide	7483
@NP	1:1000 anti-FN	7496
@NP	Invitrogen	7512
@NP	1:3000 P0 antiserum -LRB- a gift from J.	7527
@NP	1:3000 P0 antiserum	7527
@NP	a gift from J.	7548
@NP	a gift	7548
@NP	J.	7560
@NP	J.	7563
@NP	Archelos , Max-Planck Institute , Munich , Germany -RRB- .	7566
@NP	Archelos	7566
@NP	Max-Planck Institute , Munich , Germany -RRB-	7576
@NP	Max-Planck	7576
@NP	Institute , Munich , Germany -RRB-	7587
@NP	Institute	7587
@NP	Munich	7598
@NP	Germany	7606
@NP	The reaction product	7616
@NP	diaminobenzidine	7657
@NP	the sections	7679
@NP	methylene blue and Azur II	7717
@NP	methylene blue	7717
@NP	Azur II	7736
@NP	BD labeling	7749
@NP	rats	7762
@NP	4 % paraformaldehyde	7786
@NP	60 m	7810
@NP	horizontal cryostat sections	7816
@NP	the lesion/transplant area	7862
@NP	ABC -LRB- Vector Laboratories , Peterborough , UK -RRB-	7906
@NP	ABC	7906
@NP	Vector Laboratories	7911
@NP	Peterborough	7932
@NP	UK	7946
@NP	overnight	7950
@NP	BD	7961
@NP	1:200 Strep Avidin-green -LRB- Alexa Fluor 438 ; Molecular Probes -RRB- in PBS	7982
@NP	1:200 Strep Avidin-green -LRB- Alexa Fluor 438 ; Molecular Probes -RRB-	7982
@NP	1:200 Strep Avidin-green	7982
@NP	Alexa Fluor 438 ; Molecular Probes	8008
@NP	Alexa Fluor 438	8008
@NP	Molecular Probes	8025
@NP	PBS	8046
@NP	2 hr at room temperature	8054
@NP	2 hr	8054
@NP	room temperature	8062
@NP	PBS	8090
@NP	propidium iodide for confocal microscopy	8119
@NP	propidium iodide	8119
@NP	confocal microscopy	8140
@NP	the transplanted cells and monitor cell migration	8173
@NP	the transplanted cells	8173
@NP	monitor cell migration	8200
@NP	rats	8224
@NP	PBS	8248
@NP	10 µm	8256
@NP	horizontal cryostat sections	8262
@NP	FN	8314
@NP	0.5 % aqueous neutral red	8352
@NP	the completeness of the lesions	8393
@NP	the completeness	8393
@NP	the lesions	8413
@NP	10 µm coronal cryostat sections	8426
@NP	10 µm	8426
@NP	1:500 CaM-II -LRB- Zymed , San Francisco , CA -RRB-	8482
@NP	Zymed	8496
@NP	San Francisco	8503
@NP	CA	8518
@NP	Terashima	8523
@NP	et al. , 1994	8533
@NP	et al.	8533
@NP	1994	8541
@NP	0.5 % aqueous neutral red	8571
@NP	Photomicrographs at 10x	8597
@NP	Photomicrographs	8597
@NP	10x	8617
@NP	three adjacent sections at 1mmcaudal	8635
@NP	three adjacent sections	8635
@NP	1mmcaudal	8662
@NP	the lesion	8675
@NP	The extent of the lesions	8703
@NP	The extent	8703
@NP	the lesions	8717
@NP	a percentage	8746
@NP	the area	8762
@NP	the unoperated side -LRB- an average of the three sections -RRB-	8774
@NP	the unoperated side	8774
@NP	an average of the three sections	8795
@NP	an average	8795
@NP	the three sections	8809
@NP	a 5 mm	8850
@NP	grid	8865
@NP	the CST	8875
@NP	Results Lesions	8885
@NP	transplants	8909
@NP	The CST	8921
@NP	methylene blue/Azur II-stained semithin sections -LRB- Fig. 1A -RRB-	8950
@NP	methylene blue/Azur II-stained semithin sections	8950
@NP	methylene blue/Azur	8950
@NP	II-stained semithin sections	8970
@NP	Fig. 1A	9000
@NP	The corticospinal axons	9010
@NP	anterograde BD labeling in serial horizontal sections -LRB- Fig. 1C -RRB-	9056
@NP	anterograde BD labeling	9056
@NP	serial horizontal sections -LRB- Fig. 1C -RRB-	9083
@NP	serial horizontal sections	9083
@NP	Fig. 1C	9111
@NP	CaM-II immunohistochemistry in cross-sections -LRB- Fig. 2A -RRB-	9124
@NP	CaM-II immunohistochemistry	9124
@NP	cross-sections -LRB- Fig. 2A -RRB-	9155
@NP	cross-sections	9155
@NP	Fig. 2A	9171
@NP	the top cervical level	9184
@NP	the CST	9208
@NP	≈ 0.5 mm in diameter	9219
@NP	≈ 0.5 mm	9219
@NP	diameter	9230
@NP	The electrode	9240
@NP	lesions of ≈ 0.5 -- 1.0 mmin diameter on one side	9263
@NP	lesions	9263
@NP	≈ 0.5 -- 1.0 mmin diameter on one side	9274
@NP	≈ 0.5	9274
@NP	1.0 mmin diameter on one side	9279
@NP	1.0 mmin diameter	9279
@NP	one side	9299
@NP	semithin sections	9312
@NP	the lesions	9331
@NP	fluid-filled cavities	9348
@NP	macrophages and tissue debris but	9381
@NP	macrophages and tissue debris	9381
@NP	neither axons nor glia -LRB- Fig. 1A , B -RRB-	9415
@NP	axons	9423
@NP	glia -LRB- Fig. 1A , B -RRB-	9433
@NP	glia	9433
@NP	Fig. 1A , B	9439
@NP	Fig. 1A	9439
@NP	B	9447
@NP	The unavoidable minor variations in electrode positioning	9451
@NP	The unavoidable minor variations	9451
@NP	electrode positioning	9487
@NP	varying degrees of destruction of the CST -LRB- see Materials and Methods -RRB-	9521
@NP	varying degrees	9521
@NP	destruction of the CST -LRB- see Materials and Methods -RRB-	9540
@NP	destruction	9540
@NP	the CST	9555
@NP	Materials and Methods	9568
@NP	Materials	9568
@NP	Methods	9582
@NP	The extent of the lesions	9592
@NP	The extent	9592
@NP	the lesions	9606
@NP	semithin sections	9640
@NP	anterograde BD labeling -LRB- Fig. 1C -RRB-	9662
@NP	anterograde BD labeling	9662
@NP	Fig. 1C	9687
@NP	a complete series	9699
@NP	contiguous horizontal sections through the entire width of the tract	9720
@NP	contiguous horizontal sections	9720
@NP	the entire width of the tract	9759
@NP	the entire width	9759
@NP	the tract	9779
@NP	CaM-II staining in the tract 1 mm caudal to the lesion -LRB- Fig. 2F -RRB-	9796
@NP	CaM-II staining	9796
@NP	the tract 1 mm caudal to the lesion -LRB- Fig. 2F -RRB-	9815
@NP	the tract 1 mm caudal	9815
@NP	the lesion -LRB- Fig. 2F -RRB-	9840
@NP	the lesion	9840
@NP	Fig. 2F	9852
@NP	the case of incomplete lesions	9865
@NP	the case	9865
@NP	incomplete lesions	9877
@NP	the degree of destruction of the CST	9897
@NP	the degree	9897
@NP	destruction of the CST	9911
@NP	destruction	9911
@NP	the CST	9926
@NP	the area of remaining CaM-II staining -LRB- Fig. 2 -RRB-	9951
@NP	the area	9951
@NP	remaining CaM-II staining -LRB- Fig. 2 -RRB-	9963
@NP	remaining CaM-II staining	9963
@NP	Fig. 2	9990
@NP	Functional effect of lesions Rats with no functional recovery	9999
@NP	Functional effect	9999
@NP	lesions Rats with no functional recovery	10020
@NP	lesions Rats	10020
@NP	no functional recovery	10038
@NP	There	10061
@NP	19 rats	10072
@NP	the ipsilateral forepaw	10096
@NP	retrieval at any time	10124
@NP	retrieval	10124
@NP	any time	10137
@NP	the postoperative period	10153
@NP	8 weeks -LRB- n = 7 ; Fig. 3A , OE -RRB- or 24 weeks -LRB- n = 6 -RRB-	10181
@NP	8 weeks -LRB- n = 7 ; Fig. 3A , OE -RRB-	10181
@NP	n = 7 ; Fig. 3A , OE	10190
@NP	n	10190
@NP	= 7 ; Fig. 3A , OE	10192
@NP	= 7	10192
@NP	Fig. 3A , OE	10197
@NP	Fig. 3A	10197
@NP	OE	10206
@NP	24 weeks -LRB- n = 6 -RRB-	10213
@NP	n	10223
@NP	6	10227
@NP	the six cases with semithin histology	10234
@NP	the six cases	10234
@NP	semithin histology	10253
@NP	there	10273
@NP	a cyst	10283
@NP	the entire position of the CST	10304
@NP	the entire position	10304
@NP	the CST	10327
@NP	no detectable remnants of the tract on the lesioned side	10344
@NP	no detectable remnants	10344
@NP	the tract on the lesioned side	10370
@NP	the tract	10370
@NP	the lesioned side	10383
@NP	the seven cases with CaM-II staining	10405
@NP	the seven cases	10405
@NP	CaM-II staining	10426
@NP	there	10443
@NP	no visible staining in the distal tract	10453
@NP	no visible staining	10453
@NP	the distal tract	10476
@NP	the six cases with BD	10497
@NP	the six cases	10497
@NP	BD	10516
@NP	no fibers	10528
@NP	the lesion area	10555
@NP	the distal tract	10577
@NP	response to food presentation	10598
@NP	response	10598
@NP	food presentation	10610
@NP	it	10629
@NP	these rats	10647
@NP	the ipsilateral forepaw	10675
@NP	repeated shortrange distal	10708
@NP	repeated shortrange	10708
@NP	movements -LRB- wrist supination and digit flexion -RRB-	10744
@NP	movements	10744
@NP	wrist supination and digit flexion	10755
@NP	wrist supination	10755
@NP	digit flexion	10776
@NP	response	10809
@NP	food presentation	10821
@NP	they	10844
@NP	retrieval	10869
@NP	the animals	10887
@NP	the proximal arm and shoulder muscles	10911
@NP	the directed movement of extending their arms through the slit	10960
@NP	the directed movement	10960
@NP	their arms	10995
@NP	the slit	11014
@NP	the grasp	11031
@NP	range of the food	11060
@NP	range	11060
@NP	the food	11069
@NP	the contralateral forepaw	11089
@NP	the rats	11131
@NP	retrieval	11163
@NP	the ipsilateral forepaw	11178
@NP	the food	11236
@NP	the tongue or snout	11250
@NP	the defect in retrieval	11282
@NP	the defect	11282
@NP	retrieval	11296
@NP	we	11307
@NP	no impairment	11316
@NP	the ipsilateral forepaw	11333
@NP	other functions	11360
@NP	a cage edge	11399
@NP	food	11460
@NP	no asymmetry	11486
@NP	Rats with functional recovery	11500
@NP	Rats	11500
@NP	functional recovery	11510
@NP	There	11530
@NP	21 rats that retained a degree of DFR by the ipsilateral forepaw	11541
@NP	21 rats	11541
@NP	a degree of DFR	11563
@NP	a degree	11563
@NP	DFR	11575
@NP	the ipsilateral forepaw	11582
@NP	Subsequent histology	11607
@NP	each	11640
@NP	a degree of sparing of the CST fibers	11649
@NP	a degree	11649
@NP	sparing of the CST fibers	11661
@NP	sparing	11661
@NP	the CST fibers	11672
@NP	the presence of CaM-II immunostaining	11703
@NP	the presence	11703
@NP	CaM-II immunostaining	11719
@NP	the distal CST 1 mm caudal to the lesion	11744
@NP	the distal CST 1 mm caudal	11744
@NP	the lesion	11774
@NP	the three groups	11789
@NP	rats with the smaller lesions	11809
@NP	rats	11809
@NP	the smaller lesions	11819
@NP	60 % of the tract	11857
@NP	60 %	11857
@NP	the tract	11864
@NP	the ipsilateral forepaw	11876
@NP	the first time	11914
@NP	a reduced level	11944
@NP	normal levels	12012
@NP	8 weeks	12029
@NP	The two groups of rats with the larger lesions	12038
@NP	The two groups	12038
@NP	rats with the larger lesions	12056
@NP	rats	12056
@NP	the larger lesions	12066
@NP	≥ 60 % of the tract	12097
@NP	≥ 60 %	12097
@NP	the tract	12105
@NP	retrieval	12130
@NP	the second postoperative week	12146
@NP	8 weeks	12212
@NP	the rising curve	12230
@NP	greater recovery	12262
@NP	longer survivals	12307
@NP	Lesions	12325
@NP	only ≈ 1 % of the CST axons -LRB- Fig. 2G , H , a case with ≈ 400 axons -RRB-	12341
@NP	only ≈ 1 %	12341
@NP	the CST axons	12353
@NP	Fig. 2G , H	12368
@NP	Fig. 2G	12368
@NP	H	12376
@NP	a case with ≈ 400 axons	12379
@NP	a case with ≈	12379
@NP	a case	12379
@NP	≈	12391
@NP	400 axons	12392
@NP	spontaneous return of DFR	12430
@NP	spontaneous return	12430
@NP	DFR	12452
@NP	a delay of 3 weeks	12472
@NP	a delay	12472
@NP	3 weeks	12483
@NP	The data in Figure 3A	12492
@NP	The data	12492
@NP	Figure 3A	12504
@NP	bins of 1	12531
@NP	bins	12531
@NP	1	12539
@NP	19 % -LRB- n = 4 rats -RRB- , 20	12541
@NP	19 %	12541
@NP	n	12546
@NP	4 rats	12550
@NP	20	12559
@NP	39 % -LRB- n = 4 -RRB- , 40	12562
@NP	39 %	12562
@NP	n	12567
@NP	4	12571
@NP	40	12575
@NP	59 % -LRB- n = 4 -RRB- , 60	12578
@NP	59 %	12578
@NP	n	12583
@NP	4	12587
@NP	60	12591
@NP	79 % -LRB- n = 5 -RRB- , 80	12594
@NP	79 %	12594
@NP	n	12599
@NP	5	12603
@NP	80	12607
@NP	99 % -LRB- n = 4 -RRB-	12610
@NP	99 %	12610
@NP	n	12615
@NP	4	12619
@NP	100 % -LRB- n = 7 -RRB-	12627
@NP	100 %	12627
@NP	n	12633
@NP	7	12637
@NP	a whole	12650
@NP	the total number of retrievals by the ipsilateral forepaw	12659
@NP	the total number	12659
@NP	retrievals by the ipsilateral forepaw	12679
@NP	retrievals	12679
@NP	the ipsilateral forepaw	12693
@NP	r = 0.95	12741
@NP	r	12741
@NP	= 0.95	12743
@NP	the percentage	12756
@NP	surviving axons -LRB- Fig. 3B -RRB-	12774
@NP	surviving axons	12774
@NP	Fig. 3B	12791
@NP	Transplants Function Transplantations	12801
@NP	an additional group	12857
@NP	14 rats in which there had been no recovery of DFR for 8 weeks after lesion	12880
@NP	14 rats	12880
@NP	there	12897
@NP	no recovery of DFR for 8 weeks	12912
@NP	no recovery	12912
@NP	DFR for 8 weeks	12927
@NP	DFR	12927
@NP	8 weeks	12935
@NP	lesion	12949
@NP	these	12960
@NP	12	12967
@NP	transplants of OECs and 2	12979
@NP	transplants	12979
@NP	OECs and 2	12994
@NP	OECs	12994
@NP	2	13003
@NP	control injections of OEC-conditioned medium	13014
@NP	control injections	13014
@NP	OEC-conditioned medium	13036
@NP	All 14 rats	13060
@NP	DFR three times per week for 8 weeks	13093
@NP	DFR	13093
@NP	three times	13097
@NP	week for 8 weeks	13113
@NP	week	13113
@NP	8 weeks	13122
@NP	the transplantation	13136
@NP	these	13160
@NP	10	13167
@NP	a return	13177
@NP	DFR	13189
@NP	1	13209
@NP	3 weeks after transplantation	13211
@NP	3 weeks	13211
@NP	transplantation	13225
@NP	some additional increase	13261
@NP	up to 8 weeks	13286
@NP	transplantation	13306
@NP	Fig. 4	13323
@NP	Subsequent histology -LRB- see below -RRB-	13332
@NP	Subsequent histology	13332
@NP	all 10 of these rats	13375
@NP	all 10	13375
@NP	these rats	13385
@NP	the CST	13401
@NP	the lesion site	13443
@NP	transplanted OECs -LRB- Fig. 5A -RRB-	13482
@NP	transplanted OECs	13482
@NP	Fig. 5A	13501
@NP	the recovery	13516
@NP	function	13532
@NP	this long lesion plus transplant survival period -LRB- 16 weeks -RRB-	13547
@NP	this long lesion	13547
@NP	transplant survival period	13569
@NP	16 weeks	13597
@NP	the longer overall survival period -LRB- of 8 + 16 = 24 weeks -RRB-	13638
@NP	the longer overall survival period	13638
@NP	8 + 16 = 24 weeks	13677
@NP	8	13677
@NP	16 = 24 weeks	13681
@NP	the prolonged testing	13699
@NP	the failure	13740
@NP	return	13755
@NP	DFR	13765
@NP	six untransplanted rats	13772
@NP	24 weeks	13799
@NP	complete lesions	13814
@NP	Two of the transplanted rats	13844
@NP	Two	13844
@NP	the transplanted rats	13851
@NP	no return of DFR	13880
@NP	no return	13880
@NP	DFR	13893
@NP	the 8 weeks	13902
@NP	transplantation	13920
@NP	these rats	13940
@NP	subsequent histology	13952
@NP	the transplants	13985
@NP	the ascending dorsal columns	14033
@NP	the lesioned CST -LRB- Fig. 5B -RRB-	14082
@NP	the lesioned CST	14082
@NP	Fig. 5B	14100
@NP	The two rats with control injections of OECconditioned medium	14110
@NP	The two rats	14110
@NP	control injections of OECconditioned medium	14128
@NP	control injections	14128
@NP	OECconditioned medium	14150
@NP	no return of DFR	14184
@NP	no return	14184
@NP	DFR	14197
@NP	the 8 weeks	14206
@NP	injection	14224
@NP	the histology in all four of these cases	14239
@NP	the histology	14239
@NP	all four of these cases	14256
@NP	all four	14256
@NP	these cases	14268
@NP	the lesions	14295
@NP	the CST	14332
@NP	Histology FN staining of the olfactory nerve fibroblasts	14341
@NP	Histology FN staining	14341
@NP	the olfactory nerve fibroblasts	14366
@NP	the transplants	14406
@NP	solid , highly vascularized tissue masses	14450
@NP	≈ 0.5 mm in transverse diameter	14492
@NP	≈ 0.5 mm	14492
@NP	transverse diameter	14503
@NP	1.0 mm in the dorsoventral direction -LRB- Fig. 5A -RRB-	14541
@NP	1.0 mm	14541
@NP	the dorsoventral direction -LRB- Fig. 5A -RRB-	14551
@NP	the dorsoventral direction	14551
@NP	Fig. 5A	14579
@NP	BD anterograde	15138
@NP	data in four rats	15161
@NP	data	15161
@NP	four rats	15169
@NP	transplanted OECs and post transplantation return of DFR	15184
@NP	transplanted OECs	15184
@NP	post transplantation return of DFR	15206
@NP	post transplantation return	15206
@NP	DFR	15237
@NP	BD-labeled CST axons	15248
@NP	the transplants	15293
@NP	the le - sion/transplant site	15325
@NP	le	15329
@NP	sion/transplant site	15333
@NP	the BD-labeled axons	15355
@NP	primarily unbranched fibers	15399
@NP	11mmthrough the caudal part of the CST	15435
@NP	11mmthrough the caudal part	15435
@NP	the CST	15466
@NP	collateral branches	15484
@NP	right angles	15517
@NP	a lateral direction	15562
@NP	the adjacent gray matter	15587
@NP	they	15619
@NP	arborizations -LRB- Fig. 6B -- D -RRB-	15638
@NP	arborizations	15638
@NP	Fig. 6B -- D	15653
@NP	Fig. 6B	15653
@NP	D	15661
@NP	10 rats studied in cross-section histology	15668
@NP	10 rats	15668
@NP	cross-section histology	15687
@NP	P0 immunohistochemistry for peripheral myelin	15712
@NP	P0 immunohistochemistry	15712
@NP	peripheral myelin	15740
@NP	the axons passing through the transplants	15778
@NP	the axons	15778
@NP	the transplants	15804
@NP	OECs -LRB- Fig. 7 -RRB-	15839
@NP	OECs	15839
@NP	Fig. 7	15845
@NP	The P0 staining in cross-section	15854
@NP	The P0 staining	15854
@NP	cross-section	15873
@NP	us	15895
@NP	the total number of fibers crossing the transplants -LRB- Fig. 7B , C -RRB-	15907
@NP	the total number	15907
@NP	fibers crossing the transplants -LRB- Fig. 7B , C -RRB-	15927
@NP	fibers	15927
@NP	the transplants -LRB- Fig. 7B , C -RRB-	15943
@NP	the transplants	15943
@NP	Fig. 7B , C	15960
@NP	Fig. 7B	15960
@NP	C	15968
@NP	seven rats	15976
@NP	the mean and SE	15988
@NP	526 ± 58	16008
@NP	Discussion Delayed repair	16019
@NP	Discussion	16019
@NP	repair	16038
@NP	a necessity in any future clinical trials	16053
@NP	a necessity	16053
@NP	any future clinical trials	16068
@NP	the unpredictability of `` spontaneous '' repair	16112
@NP	the unpredictability	16112
@NP	`` spontaneous '' repair	16136
@NP	the prognosis for any individual spinal-injured patient	16163
@NP	the prognosis	16163
@NP	any individual spinal-injured patient	16181
@NP	up to 1 year	16240
@NP	injury	16259
@NP	the present study	16270
@NP	we	16289
@NP	a model of a delayed transplantation para - digm	16318
@NP	a model	16318
@NP	a delayed transplantation para - digm	16329
@NP	a delayed transplantation para	16329
@NP	digm	16361
@NP	The most important conclusion of the present observations	16367
@NP	The most important conclusion	16367
@NP	the present observations	16400
@NP	the previously reported reparative effect	16433
@NP	immediate transplantation OECs	16478
@NP	DFR -LRB- Li et al. , 1997 -RRB-	16512
@NP	DFR	16512
@NP	Li	16517
@NP	et al. , 1997	16520
@NP	et al.	16520
@NP	1997	16528
@NP	the transplantation	16561
@NP	8 weeks	16596
@NP	the lesion	16610
@NP	The effect of CST lesions on DFR The present results	16622
@NP	The effect	16622
@NP	CST lesions on DFR The present results	16636
@NP	CST lesions	16636
@NP	DFR The present results	16651
@NP	DFR	16651
@NP	The present results	16655
@NP	DFR	16689
@NP	at least 6 months	16710
@NP	unilateral destruction of the rat dorsal CST	16734
@NP	unilateral destruction	16734
@NP	the rat dorsal CST	16760
@NP	the top cervical level	16782
@NP	This loss of DFR	16806
@NP	This loss	16806
@NP	DFR	16819
@NP	either paralysis or any obvious weakness	16846
@NP	paralysis	16853
@NP	any obvious weakness	16866
@NP	the affected forepaw	16890
@NP	motivation	16922
@NP	retrieval movements of the affected forepaw	16969
@NP	retrieval movements	16969
@NP	the affected forepaw	16992
@NP	they	17040
@NP	The failure	17059
@NP	the ability of the proximal musculature	17086
@NP	the ability	17086
@NP	the proximal musculature	17101
@NP	the forelimb	17136
@NP	the slit and place	17157
@NP	it	17176
@NP	a position	17182
@NP	the wrist flexors	17202
@NP	the paw	17243
@NP	contact with the food pellet	17256
@NP	contact	17256
@NP	the food pellet	17269
@NP	There	17286
@NP	no obvious asymmetry	17295
@NP	the use of the forelimbs	17319
@NP	the use	17319
@NP	the forelimbs	17330
@NP	the food	17381
@NP	it	17395
@NP	The selective sensitivity of the proximal muscles to CST lesions	17416
@NP	The selective sensitivity	17416
@NP	the proximal muscles to CST lesions	17445
@NP	the proximal muscles	17445
@NP	CST lesions	17469
@NP	an anatomical and electrophysiological study	17491
@NP	Ku ¨ chler et al. , 2002	17537
@NP	Ku ¨ chler	17537
@NP	et al.	17546
@NP	2002	17554
@NP	contrast to the CST	17581
@NP	contrast	17581
@NP	the CST	17593
@NP	the rubrospinal tract	17602
@NP	a monosynaptic projection	17628
@NP	the somata	17657
@NP	major dendrites	17672
@NP	the cervical motoneurons innervating the distal forelimb muscles	17691
@NP	the cervical motoneurons	17691
@NP	the distal forelimb muscles	17728
@NP	a less direct influence over the more proximal muscles	17764
@NP	a less direct influence	17764
@NP	the more proximal muscles	17793
@NP	A complex coordinated movement such as DFR	17820
@NP	A complex coordinated movement	17820
@NP	DFR	17859
@NP	all the other necessary adjustments of body	17878
@NP	all the other necessary adjustments	17878
@NP	body	17917
@NP	position , balance , and posture	17922
@NP	the arm and paw retrieval	17968
@NP	activity of many supraspinal and intraspinal pathways	18014
@NP	activity	18014
@NP	many supraspinal and intraspinal pathways	18026
@NP	partial spinal cord lesions	18707
@NP	it	18736
@NP	both animal and human studies	18753
@NP	both animal	18753
@NP	human studies	18769
@NP	major functional recovery	18788
@NP	the absence of regeneration of the severed connections	18827
@NP	the absence	18827
@NP	regeneration of the severed connections	18842
@NP	regeneration	18842
@NP	the severed connections	18858
@NP	The mechanism of this recovery	18883
@NP	The mechanism	18883
@NP	this recovery	18900
@NP	a combination of formation of new connections	18932
@NP	a combination	18932
@NP	formation of new connections	18949
@NP	formation	18949
@NP	new connections	18962
@NP	sprouting and transfer	18981
@NP	function between pathways -LRB- Raineteau et al. , 2002 -RRB-	19007
@NP	function	19007
@NP	pathways -LRB- Raineteau et al. , 2002 -RRB-	19024
@NP	pathways	19024
@NP	Raineteau	19034
@NP	et al. , 2002	19044
@NP	et al.	19044
@NP	2002	19052
@NP	larger lesions	19077
@NP	there	19093
@NP	an element of function that is permanently lost	19118
@NP	an element	19118
@NP	function	19132
@NP	a patient	19182
@NP	an injury in which some functions are spared	19201
@NP	an injury	19201
@NP	some functions	19220
@NP	he	19247
@NP	severe and intractable disabilities	19273
@NP	the tracts that have been severed	19322
@NP	the tracts	19322
@NP	a unique type of information	19364
@NP	a unique type	19364
@NP	information	19381
@NP	the remaining tracts	19425
@NP	This model	19468
@NP	the obligatory relationship between the dorsal CST	19492
@NP	the obligatory relationship	19492
@NP	the dorsal CST	19528
@NP	a whole and DFR	19546
@NP	a whole	19546
@NP	DFR	19558
@NP	our results with incomplete lesions of the CST	19572
@NP	our results	19572
@NP	incomplete lesions of the CST	19589
@NP	incomplete lesions	19589
@NP	the CST	19611
@NP	the CST specificity	19640
@NP	partial lesions of the CST	19681
@NP	partial lesions	19681
@NP	the CST	19700
@NP	DFR	19709
@NP	a rate	19725
@NP	a degree , proportional to the number of spared CST fibers	19740
@NP	a degree	19740
@NP	proportional to the number of spared CST fibers	19750
@NP	proportional	19750
@NP	the number of spared CST fibers	19766
@NP	the number	19766
@NP	spared CST fibers	19780
@NP	This	19799
@NP	the CST	19818
@NP	specific subgroups of fibers dedicated to specific functions	19840
@NP	specific subgroups	19840
@NP	fibers dedicated to specific functions	19862
@NP	fibers	19862
@NP	specific functions	19882
@NP	The delayed return of DFR after incomplete CST lesions	19902
@NP	The delayed return	19902
@NP	DFR after incomplete CST lesions	19924
@NP	DFR	19924
@NP	incomplete CST lesions	19934
@NP	the surviving part of the CST	19995
@NP	the surviving part	19995
@NP	the CST	20017
@NP	functions	20054
@NP	even very small numbers of surviving fibers -LRB- Fig. 2H -RRB-	20069
@NP	even very small numbers	20069
@NP	surviving fibers	20096
@NP	Fig. 2H	20114
@NP	Restoration	20124
@NP	function by delayed transplants Recovery	20139
@NP	function	20139
@NP	delayed transplants Recovery	20151
@NP	ipsilateral DFR after complete unilateral CST lesions	20183
@NP	ipsilateral DFR	20183
@NP	complete unilateral CST lesions	20205
@NP	OECs	20254
@NP	the lesion site	20281
@NP	Transplants misplaced in the dorsal columns	20298
@NP	Transplants	20298
@NP	the dorsal columns	20323
@NP	only 1 -- 2 mmaway from the lesion site	20352
@NP	only 1	20352
@NP	2 mmaway from the lesion site	20359
@NP	2 mmaway	20359
@NP	the lesion site	20373
@NP	recovery of function -LRB- Fig. 5B -RRB-	20404
@NP	recovery	20404
@NP	function -LRB- Fig. 5B -RRB-	20416
@NP	function	20416
@NP	Fig. 5B	20426
@NP	we	20445
@NP	transplanted OECs migrating for up to 11 mm within the distal CST	20458
@NP	transplanted OECs	20458
@NP	up to 11 mm within the distal CST	20490
@NP	up to 11 mm	20490
@NP	11	20496
@NP	the distal CST	20509
@NP	their migratory ability	20525
@NP	tissue boundaries such as those between adjacent white matter tracts	20576
@NP	tissue boundaries	20576
@NP	those between adjacent white matter tracts	20602
@NP	those	20602
@NP	adjacent white matter tracts	20616
@NP	the cells	20663
@NP	direct contact	20691
@NP	the tract to be repaired	20711
@NP	Additional anatomical studies	20737
@NP	the mechanism	20795
@NP	the transplanted OECs	20818
@NP	return of function	20848
@NP	return	20848
@NP	function	20858
@NP	us	20872
@NP	one of the most attractive ideas	20876
@NP	one	20876
@NP	the most attractive ideas	20883
@NP	the functions	20917
@NP	regeneration of severed CST fibers	20947
@NP	regeneration	20947
@NP	severed CST fibers	20963
@NP	this and the previous study -LRB- Li et al. , 1997 -RRB-	20997
@NP	this	20997
@NP	the previous study -LRB- Li et al. , 1997 -RRB-	21006
@NP	the previous study	21006
@NP	Li	21026
@NP	et al. , 1997	21029
@NP	et al.	21029
@NP	1997	21037
@NP	we	21044
@NP	instances	21057
@NP	BD	21070
@NP	CST fibers	21095
@NP	the transplant	21115
@NP	the distal CST	21152
@NP	their normal destinations -LRB- Fig. 6B -- D -RRB-	21170
@NP	their normal destinations	21170
@NP	Fig. 6B -- D	21197
@NP	Fig. 6B	21197
@NP	D	21205
@NP	P0 staining	21209
@NP	these fibers	21232
@NP	number	21256
@NP	526 ± 58 myelinated fibers -LRB- Fig. 7B , C -RRB-	21264
@NP	526 ±	21264
@NP	58 myelinated fibers -LRB- Fig. 7B , C -RRB-	21268
@NP	58 myelinated fibers	21268
@NP	Fig. 7B , C	21290
@NP	Fig. 7B	21290
@NP	C	21298
@NP	only 1 %	21311
@NP	the total number of ≈ 50,000 CST myelinated fibers -LRB- Li et al. , 1997 -RRB-	21322
@NP	the total number	21322
@NP	≈ 50,000 CST myelinated fibers -LRB- Li et al. , 1997 -RRB-	21342
@NP	≈ 50,000 CST myelinated fibers	21342
@NP	≈ 50,000 CST	21342
@NP	Li	21373
@NP	et al. , 1997	21376
@NP	et al.	21376
@NP	1997	21384
@NP	That such small numbers of fibers	21391
@NP	That such small numbers	21391
@NP	fibers	21418
@NP	useful return of function	21437
@NP	useful return	21437
@NP	function	21454
@NP	the observation	21484
@NP	untransplanted rats	21508
@NP	the lesions	21537
@NP	only 1 % of the CaM-II-positive CST fibers	21555
@NP	only 1 %	21555
@NP	the CaM-II-positive CST fibers	21566
@NP	Fig. 2H	21598
@NP	DFR	21608
@NP	It	21636
@NP	the terminal distribution of the regenerating fibers	21672
@NP	the terminal distribution	21672
@NP	the regenerating fibers	21701
@NP	the same area as normal	21733
@NP	the same area	21733
@NP	normal	21750
@NP	we	21758
@NP	no indication of the extent to which the cortical somatotopic map is restored	21766
@NP	no indication	21766
@NP	the extent to which the cortical somatotopic map is restored	21783
@NP	the extent	21783
@NP	the cortical somatotopic map	21803
@NP	fibers	21857
@NP	example to lumbar levels	21897
@NP	example	21897
@NP	lumbar levels	21908
@NP	It	21923
@NP	a possibility	21934
@NP	transplanted OECs	21953
@NP	recovery of function , at least	21982
@NP	recovery of function	21982
@NP	recovery	21982
@NP	function	21994
@NP	part	22016
@NP	stimulation of uncut fibers	22025
@NP	stimulation	22025
@NP	uncut fibers	22040
@NP	humoral mechanisms	22059
@NP	the intense vascularization	22104
@NP	the transplants or remyelination of undetected	22135
@NP	the transplants or remyelination	22135
@NP	fibers	22202
@NP	the mechanism	22224
@NP	the functional outcome	22239
@NP	only transplants bridging the lesion	22272
@NP	only transplants	22272
@NP	the lesion	22298
@NP	function	22329
@NP	terms of future human therapy	22342
@NP	terms	22342
@NP	future human therapy	22351
@NP	the encouraging aspects of the present findings	22373
@NP	the encouraging aspects	22373
@NP	the present findings	22400
@NP	that	22430
@NP	function	22447
@NP	transplants in situations	22470
@NP	transplants	22470
@NP	situations	22485
@NP	no spontaneous recovery	22505
@NP	the beneficial reparative effects of donorOECtransplants	22560
@NP	the beneficial reparative effects	22560
@NP	donorOECtransplants	22597
@NP	transplantation	22642
@NP	2 months	22673
@NP	the CST lesions in rats	22688
@NP	the CST lesions	22688
@NP	rats	22707
@VP	were trained to use their forepaws to retrieve a piece of food	348
@VP	trained to use their forepaws to retrieve a piece of food	353
@VP	to use their forepaws to retrieve a piece of food	361
@VP	use their forepaws to retrieve a piece of food	364
@VP	to retrieve a piece of food	383
@VP	retrieve a piece of food	386
@VP	was spared	662
@VP	spared	666
@VP	was a proportionate persistence of retrieval	680
@VP	had shown no retrieval for 8 weeks after operation	748
@VP	shown no retrieval for 8 weeks after operation	752
@VP	was injected into the lesion site	844
@VP	injected into the lesion site	848
@VP	bridging the lesion site	959
@VP	resumed retrieval by the ipsilateral forepaw	984
@VP	regenerating corticospinal axons crossing the bridge	1071
@VP	crossing the bridge	1104
@VP	traveling caudally for ≈ 10 mm in the distal part of the corticospinal tract	1125
@VP	forming terminal arborizations in the spinal gray matter	1204
@VP	can occur when only ≈ 1 % of the corticospinal tract axons are present	1282
@VP	occur when only ≈ 1 % of the corticospinal tract axons are present	1286
@VP	are present	1339
@VP	abolish	1458
@VP	transplanted into the lesion site at the time of injury	1580
@VP	mediate a recovery of DFR	1636
@VP	is sufficiently stable	1879
@VP	can be expected without transplantation	1954
@VP	be expected without transplantation	1958
@VP	expected without transplantation	1961
@VP	made -LRB- Imaizumi et al. , 1998 ; Ramo ' n-Cueto et al. , 1998 , 2000 -RRB-	2095
@VP	is delayed for 2 months after complete unilateral destruction of the CST	2684
@VP	delayed for 2 months after complete unilateral destruction of the CST	2687
@VP	Pretraining	2781
@VP	were introduced to the testing cage	2917
@VP	introduced to the testing cage	2922
@VP	left paws were used	3063
@VP	were used	3073
@VP	used	3078
@VP	was scored up to an overall total of 50 retrievals	3083
@VP	scored up to an overall total of 50 retrievals	3087
@VP	use both paws more or less equally	3156
@VP	showed an asymmetry of use >	3214
@VP	were not used further	3259
@VP	used further	3268
@VP	study the functional effect of unilateral lesions of the CST	3311
@VP	have attempted to confine the lesion size and position to the CST	3528
@VP	attempted to confine the lesion size and position to the CST	3533
@VP	to confine the lesion size and position to the CST	3543
@VP	confine the lesion size and position to the CST	3546
@VP	were mounted in a stereotaxic frame	3620
@VP	mounted in a stereotaxic frame	3625
@VP	flexed	3671
@VP	insulated to within 1 mm of the tip	3859
@VP	to	3869
@VP	was inserted to a depth of 1 mm at a point 500µm lateral to the midline	3896
@VP	inserted to a depth of 1 mm at a point 500µm lateral to the midline	3900
@VP	depends mainly on the presence of the median sagittal vein	4003
@VP	is not absolutely consistent , leading to some variation in electrode placement	4077
@VP	leading to some variation in electrode placement	4107
@VP	were operated on the right and left sides	4193
@VP	were operated on the right	4193
@VP	operated on the right	4198
@VP	left sides	4224
@VP	operating at 10 V for 1 min	4362
@VP	produces circumscribed ovoid lesions of 0.5 -- 1.0 mm in diameter	4396
@VP	circumscribed ovoid lesions of 0.5 -- 1.0 mm in diameter	4405
@VP	was not much greater than that of the target CST -LRB- 0.5 mm -RRB-	4504
@VP	led to sparing of varying amounts of the target	4600
@VP	were introduced to the testing cage and the use of the right	4709
@VP	introduced to the testing cage and the use of the right	4714
@VP	was scored for 50 retrievals three times per week for 8 successive weeks	4784
@VP	scored for 50 retrievals three times per week for 8 successive weeks	4788
@VP	showed that in all cases the lesions of the CST were incomplete	4990
@VP	were incomplete	5038
@VP	was used to study the correlation between lesion size and DFR	5089
@VP	used to study the correlation between lesion size and DFR	5093
@VP	to study the correlation between lesion size and DFR	5098
@VP	study the correlation between lesion size and DFR	5101
@VP	use the ipsilateral forepaw for retrieval for the 8 weeks of postlesion testing	5176
@VP	were killed	5259
@VP	killed	5264
@VP	see below	5378
@VP	received transplants of OECs	5419
@VP	see below	5449
@VP	received injections of OEC-conditioned medium -LRB- as a control -RRB-	5466
@VP	were tested three times per week for an additional 8 weeks	5539
@VP	tested three times per week for an additional 8 weeks	5544
@VP	tested once a week for an additional 16 weeks -LRB- to a total of 24 weeks -RRB-	5665
@VP	dissected from the outer nerve and glomerular layers of the rat olfactory bulb	5762
@VP	trypsinized -LRB- 0.1 % trypsin for 15 min at 37 °C -RRB-	5842
@VP	plated onto 35mmdishes coated with poly-L-lysine	5889
@VP	coated with poly-L-lysine	5912
@VP	yielded 1 million cells , of which 50 % were p75-positive	6049
@VP	were p75-positive	6089
@VP	had shown complete absence of DFR for 8 weeks after lesion	6248
@VP	shown complete absence of DFR for 8 weeks after lesion	6252
@VP	were reanesthetized	6307
@VP	reanesthetized	6312
@VP	was reexposed	6348
@VP	reexposed	6352
@VP	Using the same	6363
@VP	tracing	6633
@VP	were used for tracing CST axons	6700
@VP	used for tracing CST axons	6705
@VP	tracing CST axons	6714
@VP	perfusing with 4 % paraformaldehyde	7088
@VP	embedded in resin	7303
@VP	cut through the lesion/transplant site	7353
@VP	treated with ethanolic sodium hydroxide for 9 min for resin etching	7393
@VP	was visualized with diaminobenzidine	7637
@VP	visualized with diaminobenzidine	7641
@VP	were counterstained with methylene blue and Azur II	7692
@VP	counterstained with methylene blue and Azur II	7697
@VP	cut through the lesion/transplant area	7850
@VP	incubated in ABC -LRB- Vector Laboratories , Peterborough , UK -RRB-	7893
@VP	washed in PBS	8080
@VP	counterstained with propidium iodide for confocal microscopy	8099
@VP	To identify the transplanted cells and monitor cell migration	8161
@VP	identify the transplanted cells and monitor cell migration	8164
@VP	immunostained for FN -LRB- as above -RRB-	8296
@VP	counterstained with 0.5 % aqueous neutral red	8332
@VP	estimating the completeness of the lesions	8382
@VP	counterstained with 0.5 % aqueous neutral red	8551
@VP	were taken of three adjacent sections at 1mmcaudal to the lesion and printed out	8621
@VP	taken of three adjacent sections at 1mmcaudal to the lesion and printed out	8626
@VP	taken of three adjacent sections at 1mmcaudal to the lesion	8626
@VP	printed out	8690
@VP	measured by placing a 5 mm squared grid over the CST	8830
@VP	placing a 5 mm squared grid over the CST	8842
@VP	squared grid over the CST	8857
@VP	is ≈ 0.5 mm in diameter	9216
@VP	produced lesions of ≈ 0.5 -- 1.0 mmin diameter on one side	9254
@VP	see Materials and Methods	9564
@VP	using semithin sections	9634
@VP	was expressed as the area of remaining CaM-II staining -LRB- Fig. 2 -RRB-	9934
@VP	expressed as the area of remaining CaM-II staining -LRB- Fig. 2 -RRB-	9938
@VP	leaving no detectable remnants of the tract on the lesioned side	10336
@VP	was no visible staining in the distal tract	10449
@VP	tracing	10519
@VP	were observed in the lesion area or in the distal tract	10538
@VP	observed in the lesion area or in the distal tract	10543
@VP	to use the ipsilateral forepaw	10668
@VP	use the ipsilateral forepaw	10671
@VP	grasping movements -LRB- wrist supination and digit flexion -RRB-	10735
@VP	were performed in response to food presentation	10791
@VP	performed in response to food presentation	10796
@VP	to achieve the directed movement of extending their arms through the slit	10949
@VP	achieve the directed movement of extending their arms through the slit	10952
@VP	extending their arms through the slit	10985
@VP	did not get within range of the food	11041
@VP	get within range of the food	11049
@VP	was restrained	11115
@VP	restrained	11119
@VP	were unable to perform retrieval with the ipsilateral forepaw	11140
@VP	to perform retrieval with the ipsilateral forepaw	11152
@VP	perform retrieval with the ipsilateral forepaw	11155
@VP	attempted to retrieve the food with the tongue or snout	11214
@VP	to retrieve the food with the tongue or snout	11224
@VP	retrieve the food with the tongue or snout	11227
@VP	walking along a cage edge	11385
@VP	climbing	11412
@VP	grooming	11422
@VP	picking up and handling food	11436
@VP	picking up	11436
@VP	handling food	11451
@VP	showed no asymmetry	11479
@VP	were 21 rats that retained a degree of DFR by the ipsilateral forepaw	11536
@VP	retained a degree of DFR by the ipsilateral forepaw	11554
@VP	destroying up to 60 % of the tract	11840
@VP	tested	11929
@VP	increased progressively and reached close to normal levels by 8 weeks	11967
@VP	increased progressively	11967
@VP	reached close to normal levels by 8 weeks	11995
@VP	destroying ≥ 60 % of the tract	12086
@VP	did not start retrieval until the second postoperative week	12116
@VP	start retrieval until the second postoperative week	12124
@VP	were still severely impaired at 8 weeks	12180
@VP	suggested that greater recovery might have been acquired at longer survivals	12247
@VP	might have been acquired at longer survivals	12279
@VP	have been acquired at longer survivals	12285
@VP	been acquired at longer survivals	12290
@VP	acquired at longer survivals	12295
@VP	Taken as a whole	12641
@VP	-LRB- r = 0.95 -RRB- with the percentage	12740
@VP	had been no recovery of DFR for 8 weeks after lesion	12903
@VP	been no recovery of DFR for 8 weeks after lesion	12907
@VP	received control injections of OEC-conditioned medium	13005
@VP	tested for DFR three times per week for 8 weeks after the transplantation	13082
@VP	began at 1 -- 3 weeks after transplantation	13200
@VP	see below	13354
@VP	had been completely destroyed	13409
@VP	been completely destroyed	13413
@VP	completely destroyed	13418
@VP	filled with transplanted OECs -LRB- Fig. 5A -RRB-	13470
@VP	see above	13832
@VP	showed no return of DFR over the 8 weeks after transplantation	13873
@VP	had been misplaced dorsally , in the ascending dorsal columns	14001
@VP	been misplaced dorsally , in the ascending dorsal columns	14005
@VP	misplaced dorsally , in the ascending dorsal columns	14010
@VP	did not occupy the lesioned CST -LRB- Fig. 5B -RRB-	14067
@VP	occupy the lesioned CST -LRB- Fig. 5B -RRB-	14075
@VP	showed no return of DFR over the 8 weeks after injection	14177
@VP	confirmed that the lesions had completely destroyed the CST	14280
@VP	had completely destroyed the CST	14307
@VP	destroyed the CST	14322
@VP	elongated to ≈ 1.0 mm in the dorsoventral direction -LRB- Fig. 5A -RRB-	14527
@VP	to ≈ 1.0 mm in the dorsoventral direction -LRB- Fig. 5A -RRB-	14537
@VP	≈ 1.0 mm in the dorsoventral direction -LRB- Fig. 5A -RRB-	14540
@VP	showed BD-labeled CST axons entering and traversing the transplants	15241
@VP	entering and traversing the transplants	15269
@VP	crossing the le - sion/transplant site	15316
@VP	left at right angles	15509
@VP	broke up into arborizations -LRB- Fig. 6B -- D -RRB-	15624
@VP	studied in cross-section histology	15676
@VP	passing through the transplants	15788
@VP	were myelinated by OECs -LRB- Fig. 7 -RRB-	15820
@VP	myelinated by OECs -LRB- Fig. 7 -RRB-	15825
@VP	crossing the transplants -LRB- Fig. 7B , C -RRB-	15934
@VP	was 526 ± 58	16004
@VP	Delayed repair	16030
@VP	means the prognosis for any individual spinal-injured patient	16157
@VP	may not be clear for up to 1 year after injury	16219
@VP	be clear for up to 1 year after injury	16227
@VP	have attempted to provide a model of a delayed transplantation para - digm	16292
@VP	attempted to provide a model of a delayed transplantation para - digm	16297
@VP	to provide a model of a delayed transplantation para - digm	16307
@VP	provide a model of a delayed transplantation para - digm	16310
@VP	be obtained when the transplantation is delayed for 8 weeks after the lesion	16544
@VP	obtained when the transplantation is delayed for 8 weeks after the lesion	16547
@VP	is delayed for 8 weeks after the lesion	16581
@VP	delayed for 8 weeks after the lesion	16584
@VP	associated with either paralysis or any obvious weakness of the affected forepaw	16830
@VP	directed retrieval movements of the affected forepaw	16960
@VP	are readily initiated	17013
@VP	initiated	17025
@VP	are abortive	17045
@VP	would be able to bring the paw into contact with the food pellet	17220
@VP	be able to bring the paw into contact with the food pellet	17226
@VP	to bring the paw into contact with the food pellet	17234
@VP	bring the paw into contact with the food pellet	17237
@VP	walking , grooming	17347
@VP	walking	17347
@VP	grooming	17356
@VP	handling the food once it has been grasped	17372
@VP	has been grasped	17398
@VP	been grasped	17402
@VP	grasped	17407
@VP	innervating the distal forelimb muscles	17716
@VP	has a less direct influence over the more proximal muscles	17760
@VP	needed to make the arm and paw retrieval effective	17953
@VP	to make the arm and paw retrieval effective	17960
@VP	make the arm and paw retrieval effective	17963
@VP	involves activity of many supraspinal and intraspinal pathways	18005
@VP	can occur in the absence of regeneration of the severed connections	18814
@VP	occur in the absence of regeneration of the severed connections	18818
@VP	seems to be an element of function that is permanently lost	19106
@VP	to be an element of function that is permanently lost	19112
@VP	be an element of function that is permanently lost	19115
@VP	is permanently lost	19146
@VP	may have an injury in which some functions are spared	19192
@VP	have an injury in which some functions are spared	19196
@VP	are spared	19235
@VP	spared	19239
@VP	may still be left with severe and intractable disabilities	19250
@VP	be left with severe and intractable disabilities	19260
@VP	left with severe and intractable disabilities	19263
@VP	have been severed	19338
@VP	been severed	19343
@VP	severed	19348
@VP	sprouting or relearning by the remaining tracts	19398
@VP	sprouting	19398
@VP	relearning by the remaining tracts	19411
@VP	is unable to restore	19446
@VP	to restore	19456
@VP	restore	19459
@VP	to fit the obligatory relationship between the dorsal CST as a whole and DFR	19485
@VP	fit the obligatory relationship between the dorsal CST as a whole and DFR	19488
@VP	indicate that within the CST specificity is less fixed	19619
@VP	is less fixed	19660
@VP	fixed	19668
@VP	does not have specific subgroups of fibers dedicated to specific functions	19826
@VP	have specific subgroups of fibers dedicated to specific functions	19835
@VP	dedicated to specific functions	19869
@VP	partially destroyed	19974
@VP	occurs only when OECs are transplanted into the lesion site	20237
@VP	are transplanted into the lesion site	20259
@VP	transplanted into the lesion site	20263
@VP	misplaced in the dorsal columns	20310
@VP	did not cause recovery of function -LRB- Fig. 5B -RRB-	20390
@VP	cause recovery of function -LRB- Fig. 5B -RRB-	20398
@VP	have seen transplanted OECs migrating for up to 11 mm within the distal CST	20448
@VP	seen transplanted OECs migrating for up to 11 mm within the distal CST	20453
@VP	migrating for up to 11 mm within the distal CST	20476
@VP	to cross tissue boundaries such as those between adjacent white matter tracts	20567
@VP	cross tissue boundaries such as those between adjacent white matter tracts	20570
@VP	To be effective	20646
@VP	be effective	20649
@VP	must be placed in direct contact with the tract to be repaired	20673
@VP	be placed in direct contact with the tract to be repaired	20678
@VP	placed in direct contact with the tract to be repaired	20681
@VP	to be repaired	20721
@VP	be repaired	20724
@VP	repaired	20727
@VP	mediate return of function	20840
@VP	is that the functions are restored by regeneration of severed CST fibers	20909
@VP	are restored by regeneration of severed CST fibers	20931
@VP	restored by regeneration of severed CST fibers	20935
@VP	crossing the transplant	21106
@VP	spare only 1 % of the CaM-II-positive CST fibers	21549
@VP	recovers spontaneously	21612
@VP	is into the same area as normal	21725
@VP	is restored	21832
@VP	restored	21835
@VP	can regenerate much further , for example to lumbar levels	21864
@VP	regenerate much further , for example to lumbar levels	21868
@VP	spared demyelinated fibers	22182
@VP	demyelinated fibers	22189
@VP	is clear	22262
@VP	bridging the lesion	22289
@VP	are able to restore function	22309
@VP	to restore function	22318
@VP	restore function	22321
@VP	are	22421
@VP	occurs	22539
@VP	is delayed for 2 months after the CST lesions in rats	22658
@VP	delayed for 2 months after the CST lesions in rats	22661
